Fluopromazine hydrochloride

盐酸三氟丙嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFluopromazine hydrochloride
Drug Alias Name三氟丙嗪盐酸盐TriflupromazinumTriflupromazina三氟普马嗪盐酸盐Triflupromazine +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsPsychotic DisordersNausea
Global Approved IndicationsPsychotic DisordersNausea
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/09/16
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersNausea

Other Information

ATC CodeN05AA05